Cardiovascular Safety Profile of Semaglutide and Variations by Sex, Race, and Kidney Function: A Systematic Review and Meta-analysis

被引:0
|
作者
Hamayal, Muhammad [1 ]
Akhtar, Chaudhary Humayun [1 ]
Ahmad, Naveed [1 ]
Awwab, Muhammad [2 ]
Shahid, Warda [1 ]
Abbasi, Hasan Shaukat [1 ]
Nadeem, Esha [1 ]
Siddiqui, Erum [3 ]
Zafar, Wadana [4 ]
Hussain, Saima [5 ]
机构
[1] Fed Med & Dent Coll, Al Farabi Ctr, Hanna Rd G-8-4, Islamabad 44080, Pakistan
[2] Quaid e Eazam Med Coll, Circular Rd, Bahawalpur 63100, Pakistan
[3] Jinnah Sindh Med Univ, Iqbal Shaheed Rd, Karachi 75510, Pakistan
[4] Univ Peshawar, Khyber Med Coll, Rd 2, Peshawar 25120, Pakistan
[5] Univ Regina Saskatoon, Innovat Pl, Saskatoon, SK S7N 3R3, Canada
关键词
D O I
10.1007/s40256-025-00727-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patients with diabetes mellitus and its complications are at increased risk for cardiovascular diseases. Semaglutide is efficacious for glycemic control and reducing the risk of major adverse cardiovascular outcomes. Although trials have provided data about cardiovascular outcomes with this agent, a meta-analysis regarding its cardiovascular safety and variations in outcomes according to sex, race and estimated glomerular filtration rate was necessary. Materials and Methods We searched the PubMed, Cochrane Library, and Clinicaltrials.gov databases and included randomized controlled trials (RCTs) where semaglutide was the intervention and major adverse cardiovascular events (MACE) or expanded MACE was the outcome. We assessed the quality of the RCTs using the Cochrane Risk of Bias tool and used the statistical software RevMan 5.4. The protocol for this review was registered on PROSPERO (CRD42024580784). Results Of 5387 articles, four RCTs were included. The risk of MACE with semaglutide was significantly lower in patients with established or a risk of cardiovascular disease (risk ratio [RR] 0.81; 95% confidence interval [CI] 0.74-0.88; p < 0.00001). The risk of expanded MACE also reduced significantly with semaglutide (RR 0.80; 95% CI 0.75-0.86; p < 0.00001). MACE risk reduction was significant in males (RR 0.78; 95% CI 0.70-0.87; p < 0.00001) and in Asian (RR 0.61; 95% CI 0.44-0.83; p = 0.002) and white (RR 0.82; 95% CI 0.73-0.90; p = 0.0001) populations. Conclusion Semaglutide provides significant advantages in terms of lowering the risk of MACE and expanded MACE and could possibly be used as a crucial component of cardiovascular risk management, particularly in populations that respond well, such as men and Asian and white populations. RegistrationPROSPERO identifier number CRD42024580784.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta-Analysis
    Maraka, Spyridoula
    Ospina, Naykky Singh
    Rodriguez-Gutierrez, Rene
    Davidge-Pitts, Caroline J.
    Nippoldt, Todd B.
    Prokop, Larry J.
    Murad, M. Hassan
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (11): : 3914 - 3923
  • [32] Cardiovascular Effects of Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
    Sobral, Milene Vitoria Sampaio
    Rodrigues, Livia Kneipp
    Barbosa, Abner Macola Pacheco
    da Rocha, Naila Camila
    Moulaz, Isac Ribeiro
    dos Santos, Joao Pedro Pereira
    Oliveira, Bruno Henrique Couto
    Moreira, Joao Lucas de Magalhaes Leal
    Pacagnelli, Francis Lopes
    Guida, Camila Mota
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025,
  • [33] Safety and efficacy profile of lenvatinib in cancer therapy: a systematic review and meta-analysis
    Zhu, Chenjing
    Ma, Xuelei
    Hu, Yuanyuan
    Guo, Linghong
    Chen, Bo
    Shen, Kai
    Xiao, Yue
    ONCOTARGET, 2016, 7 (28) : 44545 - 44557
  • [34] Effect of Mannitol on Kidney Function After Kidney Transplantation: A Systematic Review and Meta-Analysis
    Van de Laar, Stijn C.
    Schouten, Geerten N.
    IJzermans, Jan N. M.
    Minnee, Robert C.
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (07) : 2122 - 2132
  • [35] Sex difference in the safety and efficacy of bariatric procedures: a systematic review and meta-analysis
    Risi, Renata
    Rossini, Giovanni
    Tozzi, Rossella
    Pieralice, Silvia
    Monte, Lavinia
    Masi, Davide
    Castagneto-Gissey, Lidia
    Gallo, Ida Francesca
    Strigari, Lidia
    Casella, Giovanni
    Bruni, Vincenzo
    Manfrini, Silvia
    Gnessi, Lucio
    Tuccinardi, Dario
    Watanabe, Mikiko
    SURGERY FOR OBESITY AND RELATED DISEASES, 2022, 18 (07) : 983 - 996
  • [36] Contemporary Safety Profile in Double Balloon Enteroscopy: A Systematic Review and Meta-Analysis
    Al Momani, Laith
    Alomari, Mohammad
    Alsakarneh, Saqr
    Al Ta'ani, Omar
    Khazaaleh, Shrouq
    Karar, Shoura
    Boutte, Harold, Jr.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1349 - S1350
  • [37] THE EFFECT OF MANNITOL ON KIDNEY FUNCTION AFTER KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    van de Laar, Stijn
    Schouten, Geerten
    IJzermans, Jan
    Minnee, Robert
    TRANSPLANT INTERNATIONAL, 2019, 32 : 412 - 412
  • [38] Efficacy and cardiovascular safety of LAMA in patients with COPD: a systematic review and meta-analysis
    Zhang, Chuchu
    Zhang, Meng
    Wang, Yalei
    Xiong, Huaiyu
    Huang, Qiangru
    Shuai, Tiankui
    Liu, Jian
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (08) : 1391 - 1398
  • [39] Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis
    Avgerinos, Ioannis
    Michailidis, Theodoros
    Liakos, Aris
    Karagiannis, Thomas
    Matthews, David R.
    Tsapas, Apostolos
    Bekiari, Eleni
    DIABETES OBESITY & METABOLISM, 2020, 22 (03): : 335 - 345
  • [40] Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis
    Andreadis, Panagiotis
    Karagiannis, Thomas
    Malandris, Konstantinos
    Avgerinos, Ioannis
    Liakos, Aris
    Manolopoulos, Apostolos
    Bekiari, Eleni
    Matthews, David R.
    Tsapas, Apostolos
    DIABETES OBESITY & METABOLISM, 2018, 20 (09): : 2255 - 2263